CCTS Business of Science Program
The Center for Clinical & Translational Science (CCTS) would like to formally invite you to apply to a NIH funded program developed for faculty biomedical researchers.
The Business of Science program provides biomedical researchers the tools to develop into independent researchers who can clearly translate and report findings to grant sponsors, and the ability to efficiently manage the process to turn their observations in the laboratory, clinic, and community into impactful interventions.
No more than 35 researchers can attend this training, which will be held Oct. 9, 10, and 11 of 2018.
The program aims to recruit faculty early in their career, but also welcomes faculty from all ranks. We encourage all participants to continue building our research community.
The sessions are practically oriented, interactive and introduce participants to methods they can implement immediately in their research projects. Program attendees will:
- Learn to manage human and process dimensions to advance projects to conclusion, all within an environment of uncertainty.
- Learn to effectively use information, data and decision tools to leverage the best thinking to arrive at the best path to success.
- Understand the role of creativity, intuition and person-centered development in the successful application of discovery to the development of new therapies.
- Consider why anyone would choose to follow you, learn how the best leaders inspire others to follow them and be inspired to define your leadership legacy.
Register: http://j.mp/2LVWNhW
More Information: https://ccts.osu.edu/content/business-science-program
"As a junior physician scientist, I found the Business of Science course extremely helpful. This course opened my eyes to thinking ‘outside the box’ of the typical medicine and science perspective. I truly believe that the concepts and strategies outlined in the course will be invaluable in my efforts to build an effective research program and team."
W. David Arnold, MD,
Associate Professor, Division of Neuromuscular Diseases, Department of Neurology
The Ohio State Wexner Medical Center